Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
Cocrystal Pharma (Nasdaq: COCP) has announced its participation in the upcoming Life Science Innovation Northwest (LSINW) 2025 Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cocrystal Pharma (Nasdaq: COCP) has announced its participation in the upcoming Life Science Innovation Northwest (LSINW) 2025 Conference. Sam Lee, President and co-CEO, will deliver a company overview presentation on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference will take place at the Seattle Convention Center from April 23-24.
Details
News Market Reaction – COCP
The recorded move for COCP in the trading session of this news was -2.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference is being held April 23-24 at the Seattle Convention Center.
About Life Science Innovation Northwest
Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This event brings together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. Bringing together over 700 attendees, LSINW features 80+ company and research institution presentations, keynote addresses from industry leaders, engaging panel discussions on emerging trends, a dynamic startup fast pitch showdown, insightful poster presentations, and more - making it the must-attend event for the PNW’s life science community. More information is available here.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.